Authors: Schutz, J Krassnig, R Schmidhammer, H Wurst, W Lattanzi, R Negri, L

Citation: J. Schutz et al., Synthesis and pharmacological evaluation of 18,19-dehydrobuprenorphine, HETEROCYCLE, 54(2), 2001, pp. 989

Authors: Zernig, G Saria, A Krassnig, R Schmidhammer, H

Citation: G. Zernig et al., Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon, LIFE SCI, 66(19), 2000, pp. 1871-1877

Authors: Krassnig, R Schmidhammer, H Wurst, K

Citation: R. Krassnig et al., A novel method for the introduction of a 5 beta-methyl group into 4,5 alpha-epoxymorphinan-6-ones via the enol ether, HELV CHIM A, 83(2), 2000, pp. 380-383

Authors: Marki, A Monory, K Otvos, F Toth, G Krassnig, R Schmidhammer, H Traynor, JR Roques, BP Maldonado, R Borsodi, A

Citation: A. Marki et al., mu-Opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [S-35]GTP gamma S binding assays, EUR J PHARM, 383(2), 1999, pp. 209-214

Authors: Schmidhammer, H Krassnig, R Greiner, E Traynor, JR

Citation: H. Schmidhammer et al., Synthesis and biological evaluation of 14-alkoxymorphinans. 16. 14-O-alkylderivatives of the mu opioid receptor antagonist cyprodime, HETEROCYCLE, 49, 1998, pp. 489-497